• Users Online: 97
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Most cited articles *

 
 
  Archives   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
CASE REPORTS
Identification of docetaxel, cisplatin, and 5-fluorouracil regimen hypersensitivity by In vitro T-cell activation assay
Hang Huong Ling, Chun-Bing Chen, Cheng-Hsu Wang, Yen-Min Huang
October-December 2019, 6(4):184-187
DOI:10.4103/JCRP.JCRP_11_19  
  1 1,154 149
A case of acute lymphoblastic leukemia with spontaneous tumor lysis syndrome after adenosine injection
Jeng-Shiun Du, Ya-Ting Cheng, Hui-Hua Hsiao
October-December 2019, 6(4):197-199
DOI:10.4103/JCRP.JCRP_18_19  
  1 950 113
Liquefaction of metastatic radioactive iodine-refractory follicular thyroid carcinoma following radiotherapy and sorafenib
Jheng-Zong Tien, Chen-Yuan Lin
October-December 2019, 6(4):200-202
DOI:10.4103/JCRP.JCRP_19_19  
  1 743 99
Gemcitabine/cisplatin/pembrolizumab-induced posterior reversible encephalopathy syndrome
Yuh- Ching Gau, Hui- Ching Wang, Hui- Hua Hsiao, Yi- Chang Liu
July-September 2020, 7(3):127-129
DOI:10.4103/JCRP.JCRP_6_20  
  1 395 84
Successfully overcoming carboplatin hypersensitivity by continuous 48-h infusion of cisplatin plus poly (ADP-ribose) polymerase inhibitor for heavily pretreated recurrent ovarian cancer
Yu- Mei Zheng, Jyh- Ming Chow, Chia- Lun Chang, Gi- Ming Lai
July-September 2020, 7(3):134-137
DOI:10.4103/JCRP.JCRP_16_20  
  1 405 68
ORIGINAL ARTICLES
Efficacy and safety of uracil-tegafur in patients with recurrent or metastatic thymic carcinoma
Shih- Yu Huang, Cheng- Hua Huang, Harvey Yu-Li Su, Yen- Hao Chen, Tai- Jan Chiu, Yen- Yang Chen
July-September 2020, 7(3):111-115
DOI:10.4103/JCRP.JCRP_11_20  
  1 712 126
Neutrophil lymphocyte ratio is an independent prognosticator in patients with locally advanced head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil
Hsiang-Lan Lai, Yeh Tang, Chih-Yen Chien, Fu-Min Fang, Tai-Lin Huang, Tai-Jan Chiu, Shau-Hsuan Li
October-December 2019, 6(4):170-178
DOI:10.4103/JCRP.JCRP_12_19  
  1 1,659 172
REVIEW ARTICLES
Future of 5-fluorouracil in cancer therapeutics, current pharmacokinetics issues and a way forward
Sania Zafar Iqbal, Farhat Jubeen, Farooq Sher
October-December 2019, 6(4):155-161
DOI:10.4103/JCRP.JCRP_10_19  
  1 2,261 274
Thyroid hormone, PD-L1, and cancer
Yi-Ru Chen, Zi-Lin Li, Ya-Jung Shih, Paul J Davis, Jaqueline Whang-Peng, Hung-Yun Lin, Kuan Wang
October-December 2019, 6(4):162-169
DOI:10.4103/JCRP.JCRP_26_19  
  1 1,908 178
* Source: CrossRef